Quorum sensing inhibitors as Therapeutics: Bacterial biofilm inhibition

Bioorg Chem. 2023 Jul:136:106551. doi: 10.1016/j.bioorg.2023.106551. Epub 2023 Apr 19.

Abstract

The overuse and inappropriate use of antibiotics to treat bacterial infections has led to the development of multiple drug resistant strains. Biofilm is a complex microorganism aggregation defined by the presence of a dynamic, sticky, and protective extracellular matrix made of polysaccharides, proteins, and nucleic acids. The infectious diseases are caused by bacteria that flourish within quorum sensing (QS) mediated biofilms. Efforts to disrupt biofilms have enabled the identification of bioactive molecules produced by prokaryotes and eukaryotes. The QS system is quenched predominantly by these molecules. The phenomenon is also termed as quorum sensing (QS). Both synthetic and natural substances have been discovered to be useful in QS. This review describes natural and synthetic quorum sensing inhibitors (QSIs) with the potential to treat bacterial infections. It includes the discussion on quorum sensing, mechanism of quorum sensing, effect of substituents on the activity. These discoveries could result in effective therapies using far lower dosages of medications, particularly antibiotics, are currently needed.

Keywords: Antibiotics; Biofilm Formation; Drug Resistance; Inhibitors; Quorum Sensing.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology
  • Bacteria
  • Bacterial Proteins / metabolism
  • Biofilms*
  • Quorum Sensing*

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins